Zydus Cadilas US subsidiary Zydus Pharmaceuticals USA Inc has received tentative approval from the USFDA to market Pimavanserin Capsules in the strength of 34 mg USRLD Nuplazid Capsules Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with Parkinsons disease psychosis The drug will be manufactured at the groups formulation manufacturing facility at SEZ Ahmedabad The group now […]
Cipla will hold a meeting of the Board of Directors of the Company on 25 January 2022
Rane Brake Lining will hold a meeting of the Board of Directors of the Company on 27 January 2022
Oil Natural Gas Corpn announced the appointment of Dr Prabhakar DIN 09453169 has been appointment as Non-official Independent Director on the Board of the Company wef 31 December 2021
Trident has issued commercial paper aggregating Rs 50 crore on 30 December 2021
Sudarshan Chemical Industries announced that CRISIL has reaffirmed its CRISIL A1 pronounced as CRISIL A one plus rating rating to the Rs 50 crore Commercial Paper Programme of the Company
Graphite India announced that ICRA has on enhanced credit limit of Rs 1400 crore Rs 1000 crore earlier for working capital facilities of the Company reaffirmed the long term rating at [ICRA] AA pronounced ICRA double A plus and short term rating at [ICRA] A1 pronounced ICRA A one plus The outlook on the long-term rating has also been retained as Stable
Sonata Software will hold a meeting of the Board of Directors of the Company on 17 January 2022
Ritco Logistics will hold a meeting of the Board of Directors of the Company on 6 January 2022
Bajaj Finance has allotted 1805 Secured redeemable non-convertibles debentures of face value of Rs 10 lakh each aggregating Rs 18050 crore on private placement basis on 30 December 2021
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
